Cargando…

Strong negative feedback from Erk to Raf confers robustness to MAPK signalling

Protein levels within signal transduction pathways vary strongly from cell to cell. Here, we analysed how signalling pathways can still process information quantitatively despite strong heterogeneity in protein levels. We systematically perturbed the protein levels of Erk, the terminal kinase in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fritsche-Guenther, Raphaela, Witzel, Franziska, Sieber, Anja, Herr, Ricarda, Schmidt, Nadine, Braun, Sandra, Brummer, Tilman, Sers, Christine, Blüthgen, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Molecular Biology Organization 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130559/ https://www.ncbi.nlm.nih.gov/pubmed/21613978 http://dx.doi.org/10.1038/msb.2011.27

Ejemplares similares

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2016)

Network quantification of EGFR signaling unveils potential for targeted combination therapy
por: Klinger, Bertram, et al.
Publicado: (2013)

An immediate–late gene expression module decodes ERK signal duration
por: Uhlitz, Florian, et al.
Publicado: (2017)

An immediate–late gene expression module decodes ERK signal duration
por: Uhlitz, Florian, et al.
Publicado: (2017)

Global gene expression profiling analysis reveals reduction of stemness after B-RAF inhibition in colorectal cancer cell lines
por: Boerries, Melanie, et al.
Publicado: (2015)

How scaffolds shape MAPK signaling: what we know and opportunities for systems approaches
por: Witzel, Franziska, et al.
Publicado: (2012)

Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation
por: Avery, Thomas Yul, et al.
Publicado: (2022)

Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase
por: Rohrer, Lino, et al.
Publicado: (2023)

BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?
por: Herr, Ricarda, et al.
Publicado: (2015)

Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles
por: Eisenhardt, Anja E., et al.
Publicado: (2016)

Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS
por: Stelniec-Klotz, Iwona, et al.
Publicado: (2012)

A novel MCF-10A line allowing conditional oncogene expression in 3D culture
por: Herr, Ricarda, et al.
Publicado: (2011)

Profiling the MAPK/ERK dependent and independent activity regulated transcriptional programs in the murine hippocampus in vivo
por: Blüthgen, Nils, et al.
Publicado: (2017)

Membrane localization of acetylated CNK1 mediates a positive feedback on RAF/ERK signaling
por: Fischer, Adrian, et al.
Publicado: (2017)

“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014)

Negative feedback regulation of the ERK1/2 MAPK pathway
por: Lake, David, et al.
Publicado: (2016)

Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2018)

Secondhand smoke exposure induces Raf/ERK/MAPK-mediated upregulation of cerebrovascular endothelin ET(A )receptors
por: Cao, Lei, et al.
Publicado: (2011)

Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
por: Jafari, Meryem, et al.
Publicado: (2022)

Signaling output: it's all about timing and feedbacks
por: Blüthgen, Nils
Publicado: (2015)

RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010)

Lymphatic fate determination: Playing RAF with ERK
por: Deng, Yong, et al.
Publicado: (2013)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
por: Bhargava, Ajay, et al.
Publicado: (2016)

Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway
por: Lin, Minting, et al.
Publicado: (2017)

PKD controls mitotic Golgi complex fragmentation through a Raf–MEK1 pathway
por: Kienzle, Christine, et al.
Publicado: (2013)

PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
por: Wang, Xiaojuan, et al.
Publicado: (2020)

PLX8394, a RAF inhibitor, inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling
por: Wu, Chengyuan, et al.
Publicado: (2023)

ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics
por: Levidou, Georgia, et al.
Publicado: (2012)

Strong cloud–circulation coupling explains weak trade cumulus feedback
por: Vogel, Raphaela, et al.
Publicado: (2022)

Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
por: Shilo, Asaf, et al.
Publicado: (2014)

Melatonin promotes Schwann cell dedifferentiation and proliferation through the Ras/Raf/ERK and MAPK pathways, and glial cell-derived neurotrophic factor expression
por: Tiong, Yee Lian, et al.
Publicado: (2020)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
por: Ozkan-Dagliyan, Irem, et al.
Publicado: (2020)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
por: Degirmenci, Ufuk, et al.
Publicado: (2020)

Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability
por: Legewie, Stefan, et al.
Publicado: (2006)

Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway
por: Xu, Tao, et al.
Publicado: (2012)

Helicobacter pylori-Induced HB-EGF Upregulates Gastrin Expression via the EGF Receptor, C-Raf, Mek1, and Erk2 in the MAPK Pathway
por: Gunawardhana, Niluka, et al.
Publicado: (2018)

Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth
por: Rudzka, Dominika a, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rh2i89lkvm50mo9g6bnaebh55k